Group items tagged

There has been a spike in hate crimes against refugees, with much far-right anger and criticism directed at Chancellor Angela Merkel’s decision to suspend the Dublin Regulation, which stipulates that migrants and refugees can only claim asylum at a German port of entry.

The migration crisis has given fresh impetus to the PEGIDA movement (Patriotic Europeans Against the Islamization of the Occident), whose activists staged a number of demos across Germany last month.Some EU member countries are introducing temporary border controls to halt the influx of refugees and to screen those trying to enter the country illegally.

Salaita had scored successes in the early phases of his federal lawsuit. In August, US District Judge Harry Leinenweber backed Salaita’s contention that he had a binding contract with the university. Yet there was never a guarantee that even if he won at trial that the court would order his reinstatement. In September, the judge found that university officials had destroyed emails that may have contained key evidence Salaita needed to prove his case. This came after sensational revelations that top officials, including then Chancellor Phyllis Wise, had been using private email accounts to discuss the case and evade disclosure laws. Wise and another official, Provost Ilesanmi Adesida, resigned in disgrace, adding to the disarray at the frequently scandal-plagued state university.

In August, Salaita took up a year-long post as Edward W. Said Chair of American Studies at the American University of Beirut.

In December 2014, Turkish intelligence services helped to set up camps in Turkey, particularly in Hatay Province, to gather illegal migrants and provide training in preparation for the dispatch of extremist gangs to Syria. In January 2015, the Turkish MIT was involved in the operation to merge three terrorist bands, Osman Gazi, Omer bin Abdulaziz and Omer Mukhtar, into a group called the Sultan Abdulhamid Brigade, of which Omer Abdullah was appointed commander. The members of this group are trained in a camp in Bayır-Bucak in Turkey under the leadership of instructors from special operations units of the Turkish Armed Forces general command and MIT personnel. The activities of the Sultan Abdulhamid Brigade are coordinated with the activities of Jabhat al-Nusrah fighters in the north of the Syrian province of Latakia.

It is well known that on 21 September 2015, in the Syrian town of Tell Rifaat, representatives of the Syrian opposition who had received military training at a camp in Kırşehir in Turkey had delivered weapons to Jabhat al-Nusrah fighters. Deliveries of weapons to terrorist groups in Syria are reportedly still taking place, profiting from the facilities of Turkish-based foundations İnsan Hak ve Hürriyetleri ve İnsani Yardım Vakfı (IHH — Foundation for Human Rights and Freedoms and Humanitarian Relief), İmkander and Öncü Nesil İnsani Yardım Derneği.

Supplies of various forms of weapons, military equipment and ammunition are arriving from abroad via the Turkish port of İskenderun. Military equipment and supplies are transported from there through Hatay Province (Öncüpinar border crossing) to Aleppo and Idlib in Syria using vehicles belonging to IHH, İmkander and Öncü Nesil with the following Turkish registrations: 33 SU 317, 06 DY 7807, 33 SU 540, 33 SU 960, 42 GL 074 and 31 R 5487. Within Syria, the weapons and ammunition are distributed to Turkmen gangs and Jabhat al-Nusrah units.

On 15 September 2014, representatives of IHH brought supplies of weapons and medicines from Bursa through the Ceylanpınar border crossing (Reyhanlı district) by vehicle into Syria for ISIL groups. This shipment was followed and escorted through Turkey by a vehicle carrying MIT personnel.

The lawsuit alleges that the defendants donate money to tax-exempt organizations knowing that it will be used for criminal activity, such as funding the theft and destruction of private property and financing racially discriminatory practices such as Jewish-only towns and highways.

But this lawsuit reaches even more broadly than charities that fund political agendas abroad. Seventeen international corporations are named as beneficiaries of the unlawful activities of the tax-exempt entities and donors. The lawsuit calls this money loop a civil conspiracy to defraud the US government. “The settlement enterprise is a very successful industry,” the law firm states in a press release. The US-based real estate firm RE/MAX has grossed $9.5 billion for selling 26,000 new homes in the occupied West Bank, according to the lawsuit. Other corporations named are G4S, Hewlett Packard, Motorola and Volvo. Israeli banks that process international wire transfers for other defendants are also accused in the conspiracy. By targeting both the funders and the profiteers, the lawsuit aims to capture the criminal economic cycle that has helped make Israel’s occupation sustainable for everyone but Palestinians.

Separate from the civil conspiracy charges, the lawsuit also accuses Ahava–Dead Sea Laboratories, Israel Chemicals and Nordstrom department stores of the war crime of pillage. Nordstrom sells Ahava cosmetics made with Dead Sea minerals taken from the occupied West Bank.

Netanyahu’s office insisted it had not intervened over the cancellation and had not spoken to Trump about his decision. Trump’s proposed visit had clearly created problems for Netanyahu, whose office had declined to comment on Tuesday about the billionaire’s intended trip, then said he was still welcome on Wednesday. By Wednesday evening, however, Netanyahu was seeking to distance himself more forcefully from Trump. A statement released by the prime minister’s office said: “The State of Israel respects all religions and protects stringently the rights of all its citizens. At the same time, Israel is struggling with extremist Islam that is attacking Muslims, Christian and Jews as one and is threatening the entire world.” The cancellation is a blow to Trump, with Israel treated as a regular campaign stop for many US presidential candidates.

As Noah Pollak, the executive director for the Emergency Committee for Israel said: “Israelis appreciate American moral support and will always give our politicians a gracious reception. For the candidates, visiting is an easy way to be seen showing support for a close ally and gaining exposure to Middle East policy issues.” However, Pollak pointed out “trashing anyone who disagrees with him works for Trump domestically, but it won’t work with the prime minister of a close ally who is especially beloved by Republicans. Netanyahu criticized Trump, and Trump can’t attack him. The trip would have been humiliating, so he bailed.” Underlining the hints of difficulties and tensions around his proposed trip, Trump – in yet another of the brazen untruths that have become the hallmark of his campaign – had on Wednesday attempted to deny he had said he would be meeting Netanyahu despite the fact that the comment had been recorded.

He became famous within a certain world but entered public consciousness after he raised the price more than 55-fold for Daraprim in September from $13.50 per pill to $750. It is the preferred treatment for a parasitic condition known as toxoplasmosis, which can be deadly for unborn babies and patients with compromised immune systems including those with HIV or cancer. His company, Turing Pharmaceuticals AG, bought the drug, moved it to a closed distribution system and instantly drove the price into the stratosphere. He drew shocked rebukes from Congress, doctors and presidential candidates, and brought public attention to the rising prices of older drugs. Donald Trump called Shkreli a “spoiled brat,” and the BBC dubbed him the “most hated man in America.” Bernie Sanders, the Democratic presidential candidate, rejected a $2,700 campaign donation from him, directing it to an HIV clinic. A spokesman said the campaign would not keep money “from this poster boy for drug company greed.” All the criticism seemed at first to have some impact and Shkreli said he would lower the price. Then he reneged. When Hillary Clinton tried one more time last month to get him to cut the cost, he dismissed her with the tweet “lol.” At a Forbes summit in New York this month, wearing a hooded sweatshirt, he said if he could have done it over, “I probably would have raised the price higher,” adding, “My investors expect me to maximize profits.”

Shkreli did further damage to his public image with other acts and boasts. He spent millions on the only copy of a Wu-Tang Clan album that music fans are desperate to hear and then told Bloomberg Businessweek that he had no immediate plans to listen to it. He takes often to Twitter and message boards, bragging about his business strategies, musical tastes and politics; he live-streams from his office for long stretches. The SEC complaint and federal indictment lay out a series of schemes and cover-ups carried out by Shkreli. Capers said authorities began investigating him as early as 2014.

Barely 23, he was managing hedge fund Elea Capital in New York and lost it all in 2007. Around then, a trade with Lehman Brothers ended with a $2.3 million judgment against him, prosecutors said. In 2010, he lost his clients’ $3 million investment in his new fund, MSMB Capital. In 2011, he bet that shares of Orexigen Therapeutics Inc. would fall and wound up owing $7 million to his broker, Merrill Lynch, authorities said. He couldn’t pay, and he, an unnamed accomplice and MSMB Capital eventually extinguished the debt with a $1.35 million settlement, they said. Part of that money came from his next firm, authorities said. After the collapse of MSMB Capital, Shkreli launched MSMB Healthcare with about $5 million from 13 investors. He paid himself “far in excess” of the agreed-upon 1 percent management fee and 20 percent profit incentive, according to the SEC.

Shkreli then used cash from MSMB Healthcare to invest in Retrophin, the pharmaceutical company he founded in 2011, even though it “had no products or assets,” prosecutors said. Later, he used the assets of Retrophin to repay angry investors in his hedge funds, prosecutors said. Shkreli is confident that he will be cleared of the charges, according to a statement on his behalf. Shkreli is particularly disappointed that his litigation with Retrophin has become a government enforcement matter, according to the statement. He also denied the charges regarding the MSMB entities, which he said involve complex accounting matters that prosecutors and the SEC fail to understand, according to the statement. “It is no coincidence that these charges, the result of investigations which have been languishing for considerable time, have been filed at the same time of Shkreli’s high-profile, controversial and yet unrelated activities,” according to the statement. “The government suggested that Mr. Shkreli was involved in a Ponzi scheme. Ponzi victims do not make money, yet Mr. Shkreli’s investors enjoyed strong results.”

As Shkreli’s losses mounted, so did his lies. He fabricated portfolio statements and, with his lawyer’s help, deceived the SEC and outside accountants. He backdated records, manufactured a phony loan agreement between Retrophin and a hedge fund, and created sham consulting agreements with Retrophin as a way to route the company’s cash to his earlier investors. Greebel, the arrested lawyer, made sure Retrophin’s outside accountants were unaware of Shkreli’s financial maneuvers and helped him concoct the consulting agreements used to repay the hedge fund investors, the U.S. said. The cases mirror a lawsuit brought by Retrophin. Shkreli blithely dismissed his old company’s claims, saying, “The $65 million Retrophin wants from me would not dent me. I feel great. I’m licking my chops over the suits I’m going to file against them.” Earlier, he had denied wrongdoing in a post on InvestorsHub after Retrophin disclosed it had received a subpoena from federal prosecutors and the preliminary findings from its own investigation of Shkreli. He called the company’s allegations “completely false, untrue at best and defamatory at worst.”

“Every transaction I’ve ever made at Retrophin was done with outside counsel’s blessing,” he said on the investment blog in February, without identifying the lawyers. When Shkreli was working for Cramer’s firm, he was still a teenager. After recommending successful trades, Shkreli eventually set up his own hedge fund, quickly developing a reputation for trashing biotechnology stocks in online chatrooms and shorting them, to enormous profit. Widely admired for his intellect and sharp eye, he set up Retrophin to develop drugs and acquire older pharmaceuticals that could be sold for higher profits. Turing, which is less than a year old and has raised $90 million in financing, has followed a similar strategy with the purchase of drugs, including Daraprim. Shkreli recently bought a majority stake in KaloBios Pharmaceuticals Inc. after Turing received a warning from the New York attorney general that the distribution network for Daraprim may violate antitrust laws. State officials made their concerns known to Turing and Shkreli in an Oct. 12 letter obtained by Bloomberg.

KaloBios recently acquired the license for benznidazole, a standard treatment for Chagas, a deadly parasitic infection most common in South and Central America. The firm announced plans to increase the cost from a couple hundred dollars for two months to a pricing structure like that for hepatitis-C drugs, which can run to nearly $100,000 for 12 weeks.

With the federal charges and regulatory actions, Shkreli could be banned from running a public company, which could put the future of KaloBios into question. Trading in KaloBios shares was halted after the stock fell 53 percent. It’s less clear what the impact could be on Turing, which is closely held.

Federal authorities will have to ask a judge to impose an asset freeze if they want to guarantee Shkreli doesn’t dispose of ill-gotten gains. The charges suggest that a small group of health-care firms—ones that acquire the rights to drugs and significantly increase their prices—is drawing the scrutiny of regulators and prosecutors, with a possible chilling effect on aggressive drug-pricing strategies. Legislators are already paying attention. A hearing of the Senate Special Committee on Aging on Dec. 9 scrutinized such tactics. Before Shkreli started Turing, Retrophin raised the price of Thiola, used to treat a rare condition causing debilitating recurrences of kidney stones, from $1.50 a pill to $30. “Some of these companies seem to act more like hedge funds than traditional pharmaceutical companies,” said Senator Susan Collins, a Maine Republican who ran the recent hearing. George Scangos, CEO of biotechnology giant Biogen Inc., went further, saying in an interview, “Turing is to a research-based company like a loan shark is to a legitimate bank.”

Captain Robert Smith, then commander of all East Coast-based Seals and now a senior official in the department of the Navy, ultimately cleared the men of all charges. He said eyewitness accounts of what took place were inconsistent, and “did not give me enough confidence in their overall accuracy to hold the accused accountable for assaults or abuse”.

The President has approved a current cap of less than 50 troops, with the first contingent expected to be about two dozen. But more could be sent, the official said.

There will be additional Special Operations forces available for raids against targets in both Syria and Iraq when high-value ISIS targets are identified, the official said.The U.S. support for the anti-ISIS fighters has a crucial goal of making them capable of challenging ISIS control of its unofficial capital, Raqqa. The effort is to make them able to isolate, take control, and "ultimately hold" the key city, the official said. There is no prediction of when that might be possible.

The U.S. will also boost its military footprint in confronting ISIS in Syria by deploying A-10 and F-15 fighter jets to Incirlik Air Base in Turkey. And the U.S. is also eying the establishment of a Special Forces task force in Iraq to boost U.S. efforts to target ISIS and its leaders, the administration official said. President Barack Obama has also authorized enhancing military aid to Jordan and Lebanon to help counter ISIS.

Obama has long resisted an American military presence on the ground to combat ISIS in Iraq and Syria but has reluctantly escalated U.S. involvement in that fight over time since launching the military effort in 2014.The number of U.S. military forces in Iraq has swelled to more than 3,500 since Obama first announced the deployment of up to 300 American military advisers to Iraq in June 2014.U.S. Special Ops have previously conducted some secretive missions on the ground in Syria as well. But the deployment marks the first permanent presence of U.S. ground troops in Syria since the U.S. began leading an international effort last year to confront ISIS, the militant Islamist group which now controls broad swaths of territory in Iraq and Syria.

The troops to be sent to Syria are not expected to serve on the front lines with rebel forces and, according to a U.S. official, they will rotate in and out of Syria from the existing U.S. base in Irbil, Iraq.But they are entering a very hot combat zone and have the right to engage the enemy if they come under fire. They could also join Syrian and Kurdish forces on raids if they get explicit permission from Washington.

"Both of the pilots were retrieved dead. Our comrades opened fire into the air and they died in the air," Alpaslan Celik said near the Syrian village of Yamadi, close to where the plane came down, holding what he said was a piece of a pilot's parachute. In a further sign of a growing fallout over Syria, Syrian rebel fighters who have received U.S. arms said they fired at a Russian helicopter, forcing it to land in territory held by Moscow's Syrian government allies.Turkey called this week for a U.N. Security Council meeting to discuss attacks on Turkmens, who are Syrians of Turkish descent, and last week Ankara summoned the Russian ambassador to protest against the bombing of their villages.About 1,700 people have fled the mountainous area due to fighting in the last three days, a Turkish official said on Monday. Russian jets have bombed the area in support of ground operations by Syrian government forces.

Abaaoud, a citizen of Belgium of Moroccan descent, was well known as a violent radical miscreant linked to an Islamic cell in Verviers, Belgium, that did all sorts of mean, murderous crap.  As far as Belgian and French authorities were concerned, he had been an item long before Paris.

Washington believes the group is responsible for the 2012 attack on the US consulate in Benghazi that killed the ambassador and three other Americans.  In November, the United Nations blacklisted Ansar al-Sharia Benghazi and its sister group, Ansar al-Sharia Derna, over links to Al-Qaeda and for running camps for the Islamist State group.  So there you have your soundbite.  The Paris outrage: Made in Libya.  Not Syria.  And brought to us by the people who killed Christopher Stevens in Benghazi. I am sure that Hillary Clinton is grateful to the French police for botching the raid to capture Abaaoud and pumping 5000 rounds into his apartment instead of capturing him; otherwise, he might have become a lively topic of interest and curiosity and the right wing could have cooked off the Benghazi! munitions through election day.  For that matter, it seems unlikely that the governments of the West, or the media cheerleaders thirsting for a rousing good vs. evil narrative, are very interested in exploring the morally fraught issue of blow back from the spectacular Libyan disaster, either. To sum up: the alleged and now reportedly deceased architect of the Paris attacks, Abdelhamid Abaaoud, did not fight “for IS.”  He fought “with” Katibat al-Battar al-Libi, a Libyan outfit whose presence in Syria predates that of ISIS.  Even after Katibat al-Battar al-Libi decided to pledge allegiance to ISIS, it retained its independent identity.  And it would appear unlikely that Abaaoud, as a European of Moroccan descent, would be a central figure in the brigade, whose personnel, funding, and mission seem to have largely emanated from Libya.

Despite his seemingly junior status in an autonomous militia, it is possible that Abaaoud was recruited by al-Baghdadi to commit the Paris outrage.  But foreign fighters flock to Syria not only to accumulate general jihadi merit, but also to acquire skills they could apply in their own struggles.  And Abaaoud may have gone to the Syrian war zone to hook up with an extremely capable Libyan outfit and acquire the experience and connections to fulfill his own ambitions for mayhem in Europe, and not necessarily to support the global or even local objectives of the IS caliphate.  So it is by no means axiomatic that Abaaoud returned to Europe with the mission to execute a high-level ISIS strategy. Instead, Abaaoud might have been an angry guy with the skills, resources, and inclination to commit mass murder on his own kick.  The police were already after him big time after the Verviers raid in January (we are now told that Abaaoud was “on” or a “candidate for” a spot on the drone assassination assignment list, but I wonder if this is post-hoc ass-covering).  So maybe he and his friends decided to pull the pin, and go out in a big way. I doubt we’ll ever get the full story.  But “Paris: Made in Libya” is an honest hook.

For all we know, the NYPD might be bombarding apartment houses with radiation while people are inside or peering inside vehicles on the street as unwitting passersby are exposed to radiation. The city’s position—that New Yorkers have no right to know if that is happening or not—is so absurd that one can hardly believe they’re taking it. These are properly political questions. And it’s unlikely a target would ever notice. “Once equipped, the van—which looks like a standard delivery van—takes less than 15 seconds to scan a vehicle,” Fox News reported after looking at X-ray vans owned by the federal government. “It can be operated remotely from more than 1,500 feet and can be equipped with optional technology to identify radioactivity as well.”

And since the technology can see through clothing, it is easy to imagine a misbehaving NYPD officer abusing it if there are not sufficient safeguards in place. Trusting the NYPD to choose prudent, sufficient safeguards under cover of secrecy is folly. This is the same department that spent 6 years conducting surveillance on innocent Muslims Americans in a program so unfocused that it produced zero leads—and that has brutalized New York City protestors on numerous occasions. Time and again it’s shown that outside oversight is needed.Lest readers outside New York City presume that their walls still stand between them and their local law enforcement agency, that isn’t necessarily the case. Back in January, in an article that got remarkably little attention, USA Today reported the following:

At least 50 U.S. law enforcementagencies have secretly equipped their officers with radar devices that allow them to effectively peer through the walls of houses to see whether anyone is inside, a practice raising new concerns about the extent of government surveillance. Those agencies, including the FBI and the U.S. Marshals Service, began deploying the radar systems more than two years ago with little notice to the courts and no public disclosure of when or how they would be used. The technology raises legal and privacy issues because the U.S. Supreme Court has said officers generally cannot use high-tech sensors to tell them about the inside of a person's house without first obtaining a search warrant. The radars work like finely tuned motion detectors, using radio waves to zero in on movements as slight as human breathing from a distance of more than 50 feet. They can detect whether anyone is inside of a house, where they are and whether they are moving.